Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 22 of 39

  1. NORD-STAR

    The George Institute

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  2. Nafamostat mesilate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  3. Naglazyme

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis VI

    approved small molecule completed

    1 trial

  4. Naldebain

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule active

    1 trial

  5. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial

  6. Naproxen

    Teva Pharma GmbH

    Menorrhagia

    approved small molecule completed

    1 trial

  7. Neffy

    Ars Pharmaceuticals Irl Limited

    Allergic Reactions

    approved small molecule active

    1 trial

  8. Nelfinavir and Omeprazole

    Jasper Therapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

  9. Neovascular Age-related Macular Degeneration

    Novartis Pharmaceuticals

    Neovacular Age-related Macular Degeneration

    approved other completed

    1 trial

  10. Nerve block with liposomal bupivacaine and intravenous analgesia

    The First People's Hospital of Lianyungang

    Liposomal Bupivacaine

    approved other active

    1 trial

  11. NextDose (nextdose.org)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombosis Embolism

    approved other active

    1 trial

  12. Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Glycogen storage disease type II or acid maltase deficiency, Pompe disease

    approved small molecule active

    1 trial

  13. Nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stable Angina

    approved small molecule completed

    1 trial

  14. Nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-obstructive Coronary Artery Disease

    approved small molecule terminated

    1 trial

  15. Nicorandil 5mg tid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Bypass Graft

    approved small molecule active

    1 trial

  16. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  17. Nicotine Nasal Spray

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  18. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    3 trials

  19. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule terminated

    3 trials

  20. Nicotine patch - transdermal

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  21. Nifedipine 30 MG

    Yang I. Pachankis

    Severe Acute Respiratory Syndrome-related Coronavirus

    approved small molecule completed

    1 trial

  22. Nifedipine GITS

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  23. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  24. Nocardia rubra Cell Wall Skeleton

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcer

    approved small molecule active

    1 trial

  25. Norepinephrine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule completed

    1 trial

  26. Norfloxacino Sandoz 400 mg comprimidos EFG

    The George Institute

    Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.

    approved small molecule active

    1 trial

  27. Normal Saline

    Nanjing Zenshine Pharmaceuticals

    Breast Feeding

    approved small molecule completed

    1 trial

  28. Normal saline

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  29. OBU-BC-II-206

    The First People's Hospital of Lianyungang

    HER2 Positive Breast Cancer

    approved small molecule active

    1 trial

  30. OHIRC-20150866

    The George Institute

    Risk of stroke by Atrial Fibrillation

    approved small molecule active

    1 trial

  31. OM 85OLDER

    Fondazione Telethon ETS

    Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.

    approved small molecule active

    1 trial

  32. OMACOR

    United Therapeutics Europe Ltd

    Non-Alcoholic Fatty Liver Disease

    approved small molecule completed

    1 trial

  33. ONTAK (denileukin difitox, DAB389IL-2)

    LIGAND PHARMACEUTICALS INC

    Lymphoma, T-Cell, Cutaneous

    approved small molecule completed

    1 trial

  34. OOPEN+BBCC

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Overdose

    approved small molecule completed

    1 trial

  35. OROS hydromorphone

    Janssen Cilag International NV

    Cancer Pain

    approved small molecule completed

    1 trial

  36. OXALIPLATIN, CAPECITABINE

    Disc Medicine

    Locally advanced or metastatic gastro-intestinal carcinoma

    approved small molecule active

    1 trial

  37. Ocrevus 300 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications]

    approved small molecule active

    1 trial

  38. Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

    Takeda

    Hemophilia A

    approved mab completed

    2 trials

  39. Ofatumumab

    Novartis Pharmaceuticals

    Relapsing Multiple Sclerosis

    approved mab completed

    1 trial

  40. Offer of voucher for cost-free Nicotine Replacement Therapy

    United Therapeutics Europe Ltd

    Tobacco Smoking

    approved small molecule completed

    1 trial

  41. Ofirmev

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  42. Olanzapine

    United Therapeutics Europe Ltd

    Acute Agitation, Behavioural Emergency

    approved small molecule terminated

    1 trial

  43. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    AML (Acute Myeloid Leukemia)

    approved small molecule active

    1 trial

  44. Omega 3-Atorvastatin

    United Therapeutics Europe Ltd

    Dyslipidemias

    approved small molecule active

    1 trial

  45. Optimal hypoglycemic treatment

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    approved other active

    1 trial

  46. Oral Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    HIV-1-infection

    approved small molecule completed

    1 trial

  47. Oral Zonisamide Therapy

    Affiliated Hospital of Nantong University

    Epilepsies, Partial

    approved small molecule active

    1 trial

  48. Oral consumption

    BRIGHT MINDS BIOSCIENCES INC.

    Growth Acceleration

    approved other completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.